Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies.
about
Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2Vitamin D Levels Are Associated with Expression of SLE, but Not Flare Frequency.Confirmation of anti-DFS70 antibodies is needed in routine clinical samples with DFS staining pattern.The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.Detection of autoantibodies using chemiluminescence technologiesApplication of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells.Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model.Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.The Clinical Relevance of Anti-DFS70 Autoantibodies.The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics.Maternal outcomes and follow-up of preterm and term neonates born to mothers with systemic lupus erythematosus.Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies.Improving Appropriate Access to Care With Central Referral and Triage in Rheumatology.The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status
P2860
Q33361237-8DE0C7B3-9CF4-42BF-803D-0ABE85264E42Q34652383-356D7B72-1604-49EA-98D1-C0A27A2F9D68Q36793026-AAE6A468-4CE5-4EFE-8D7F-D87461167653Q38531451-F06A1277-4FB0-43EC-B2FE-1C66765DEAEEQ38622712-28EE1938-93CF-4D68-A3DC-05E10E834C2BQ38813885-64918A3E-A044-4708-8A86-1BB8999C5C13Q38824959-0E064DFE-DC19-47BA-A637-E042ED92D242Q38851096-B18DB649-6185-4B25-9F71-29BFE5A36142Q38879029-7075C32E-8209-47CE-AA11-DAD56350648FQ38899125-73D68024-3847-4F54-ADB3-93C2024A67B0Q39662415-74B28222-A58A-476C-8C1B-55E4AE6C34FEQ39716599-B7E43214-8AE0-43B2-8B79-A5CB1A17B28FQ40056269-2D30500A-FFAB-4201-8B0E-DB7DB7228943Q40237986-E651DE1F-214F-44BB-AA5C-174B0AF4ADB7Q55100401-E9BF373F-FF80-4B16-871E-F574B516D06DQ56837255-2C44F965-3B2F-47F9-93BD-18FF8891F8F6
P2860
Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical and serological featu ...... sitive antinuclear antibodies.
@ast
Clinical and serological featu ...... sitive antinuclear antibodies.
@en
type
label
Clinical and serological featu ...... sitive antinuclear antibodies.
@ast
Clinical and serological featu ...... sitive antinuclear antibodies.
@en
prefLabel
Clinical and serological featu ...... sitive antinuclear antibodies.
@ast
Clinical and serological featu ...... sitive antinuclear antibodies.
@en
P2093
P2860
P1433
P1476
Clinical and serological featu ...... sitive antinuclear antibodies.
@en
P2093
Christie Fitch-Rogalsky
Dianne P Mosher
James Wick
Liam Martin
Susan G Barr
Terri Lupton
Whitney Steber
P2860
P304
P356
10.1371/JOURNAL.PONE.0093812
P407
P577
2014-04-04T00:00:00Z